Answer
Ivabradine is indicated for patients with NYHA class II–IV chronic heart failure with systolic dysfunction, sinus rhythm and heart rate ≥75 bpm, in combination with standard therapy including beta-blockers, or when beta-blocker therapy is contraindicated or not tolerated.
Sources for this answer
- Ivabradine 5 mg Film-coated TabletsViatris (formerly Mylan or Upjohn) · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked